Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of an Integral Strategy for Joint Management of DM2 and Pulmonary TB in Orizaba, Veracruz.

NCT03277742 is registered in ClinicalTrials.gov with Instituto Nacional de Salud Publica, Mexico as lead sponsor.

NCT NCT03277742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03277742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of an Integral Strategy for Joint Management of DM2 and Pulmonary TB in Orizaba, Veracruz.
Lead sponsor
Instituto Nacional de Salud Publica, Mexico
Phase
Not applicable
Overall status
Withdrawn
Start date
September 20, 2017
Completion date
December 31, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, pulmonary tuberculosis